Netherlands· NL-c714a69bbbb3
Dostinex, tabletten 0,5 mg
A cabergoline product containing cabergoline, registered in Netherlands by Originalis B.V.. The same ATC class is registered in 13 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Cabergoline is registered in 13 of 19 countries.
Countries holding a registration under ATC G02CB03 (cabergoline), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 8 of them publish a price we can compare per daily dose
Cabergoline · ATC G02CB03
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
Price per daily dose
What a daily dose of cabergoline costs, country by country.
Normalised to the WHO defined daily dose (0.5 mg), the median price runs from $3.40 in France to $11.81 in Switzerland — a ×3.5 gap.
- 3 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Cabergoline · price per daily dose (0.5 mg)
USD · FX 28 Sept 2026
- CH Switzerland$11.81
- IT Italy$4.08
- FR France$3.40
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- CABERGOLINE
- Manufacturer
- Originalis B.V.
- Country
- Netherlands (NL)
- ATC code
- G02CB03
- ATC class
- Cabergoline
- Defined daily dose
- 0.5 mg, O
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_id128298//15375
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
65 interactions on record for cabergoline.
Graded by severity as the source publishes them — 3 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Cabergoline · interactions on record
65 records
- 3 severe
- 17 moderate
- 45 info
Most severe, free to view
- LorcaserinA08AA11severe
- ErythromycinJ01FA01severe
- ClarithromycinJ01FA09severe
- MetoclopramideA03FA01moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Cabergoline in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomCabergoline 500microgram tabletsMilpharm Ltd
- PolandDostinexDelfarma Sp. z o.o.
- United StatesCabergolineA-S Medication Solutions
- SwedenCabenex 0,5 mg TablettRenata Pharmaceuticals (Ireland) Limited
- CzechiaDOSTINEXPfizer, spol. s r.o., Praha
- FranceCABERGOLINE ARROW 0,5 mg, comprimé sécableARROW GENERIQUES
- ItalyCABERGOLINA AUROBINDOAUROBINDO PHARMA ITALIA S.R.L.
- IrelandDostinex 500 microgram tabletsPfizer Healthcare Ireland Unlimited Company
Authorised across Europe · EMA
The same active substance is authorised in 25 EEA countries. Names it is sold under:
- Austria · Cabaseril, Dostinex
- Belgium · Cabergoline Teva, Dostinex
- Bulgaria · Достинекс
- Cyprus · Dostinex
- Czechia · Dostinex
- Germany · Cabaseril, Cabergoletten
- Denmark · Cabenex, Cabergolin Teva
- Spain · Cabergolina Teva, Dostinex
- Finland · Cabaser, Dostinex
- France · Cabergoline Arrow, Cabergoline Biogaran
- United Kingdom (Northern Ireland) · Cabaser, Cabergoline Aspire Pharma
- Greece · Dostinex
- Croatia · Dostinex
- Ireland · Cabaser, Cabergoline Renata Pharmaceuticals (Ireland)
- Iceland · Dostinex
- Italy · Cabaser, Cabergolina Aurobindo
- Luxembourg · Cabergoline Teva, Dostinex
- Latvia · Dostinex
- Malta · Cabergoline Aurobindo, Cabergoline Doc
- Norway · Cabergoline Renata Pharmaceuticals (Ireland), Dostinex
- Poland · Dostinex
- Portugal · Cabergolina Generis, Cabergoline 0.5 Mg Tablets
- Romania · Dostinex
- Sweden · Cabenex, Cabergoline Ratiopharm
- Slovakia · Cabest
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/db97a7a4-c033-4d05-a6df-f2ce7467a569 GET /v1/drugs/db97a7a4-c033-4d05-a6df-f2ce7467a569?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tablet",
"route": "Oraal gebruik",
"soort": "RVG",
"source": "cbg_meb",
"smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h15375_smpc.pdf",
"strength": null,
"atc_label": "Cabergoline",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg128298",
"excipients": [
"LACTOSE 0-WATER",
"LEUCINE, (L-) (E 641)"
],
"substances": [
"CABERGOLINE"
],
"leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h128298.pdf",
"authorised_at": "2021/05/19",
"procedure_number": null,
"dispensing_status": "Uitsluitend recept",
"registration_number": "128298//15375",
"additional_monitoring": "N"
}See everything about cabergoline.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.